Cargando…
Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study
Observational studies report a reduction of COPD exacerbations in patients treated with β-blockers. In contrast, the Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (BLOCK COPD) randomised controlled trial which excluded COPD patients with cardiovascu...
Autores principales: | Karimi, Leila, Lahousse, Lies, De Nocker, Phebe, Stricker, Bruno H., Brusselle, Guy G., Verhamme, Katia M.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236616/ https://www.ncbi.nlm.nih.gov/pubmed/34195251 http://dx.doi.org/10.1183/23120541.00624-2020 |
Ejemplares similares
-
β(2)-Adrenergic Receptor (ADRB2) Gene Polymorphisms and Risk of COPD Exacerbations: The Rotterdam Study
por: Karimi, Leila, et al.
Publicado: (2019) -
Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study
por: Terzikhan, Natalie, et al.
Publicado: (2016) -
Incidence and predictors of asthma exacerbations in middle-aged and older adults: the Rotterdam Study
por: de Roos, Emmely W., et al.
Publicado: (2021) -
Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study
por: Arinze, Johnmary T., et al.
Publicado: (2020) -
COPD is associated with an increased risk of peripheral artery disease and mortality
por: Terzikhan, Natalie, et al.
Publicado: (2018)